Physician profile
John Michael Shepard
NPI 1952958548
$1,464.14
in general payments reported to CMS, 2019-2025
21 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.85 · 2023: $72.84 · 2024: $120 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.03 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $238.28 | 2025 | |
| Organon LLC | $188.12 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $178.64 | 2025 | Dupixent |
| Leo Pharma INC. | $100.53 | 2025 | Adbry |
| Amgen INC. | $98.03 | 2024-2025 | Krystexxa, Otezla |
| Abbvie INC. | $95.07 | 2025 | |
| Arcutis Biotherapeutics, INC. | $78.49 | 2025 | Zoryve |
| Si-Bone, INC. | $77.04 | 2024-2025 | |
| Horizon Therapeutics Plc | $59.97 | 2022-2023 | Krystexxa |
| Fidia Pharma USA INC. | $51.63 | 2023-2024 | Triluron, Hymovis, Hyalgan |
| E.R. Squibb & Sons, L.L.C. | $47.62 | 2025 | Sotyktu |
| Merz Pharmaceuticals, LLC | $43.10 | 2024-2025 | Xeomin |
| Sun Pharmaceutical Industries INC. | $38.85 | 2025 | |
| Ucb, INC. | $29.95 | 2025 | Bimzelx |
| Merz North America, INC. | $28.43 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $26.92 | 2025 | |
| Janssen Biotech, INC. | $20.42 | 2025 | Tremfya |
| Otsuka America Pharmaceutical, INC. | $18.02 | 2023 | Nuedexta |
| Lilly USA, LLC | $17.45 | 2025 | Zepbound |
| Lnhc, INC | $14.06 | 2025 | Zelsuvmi |
| Kci USA, INC. | $13.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shepard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.